News
Current news
New article: “Peptideins: Navigating the gray zone of the proteome”
21 07 2026
Research group: Protein Folding and Conformational Diseases
IBB Secures Funding for Four Projects in the AEI call "Generación de Conocimiento 2025"
20 07 2026
The awards will support cutting-edge research in biomedicine, fertility, infectious diseases and diagnostic technologies, including two FPI predoctoral fellowships
New article: ““Too soon to tell”? The potential of tools like AggrescanAI for novel drug discovery and development”
14 07 2026
Research group: Protein Folding and Conformational Diseases
New article: “A pan-vertebrate signaling motif controls the molecular function of intracellular AQP12”
10 07 2026
Research group: Comparative Molecular Physiology
New article: “Can we vaccinate the brain? The promise of precision immunology”
09 07 2026
Research group: Protein Folding and Conformational Diseases
The IBB-UAB researcher Aura Muntasell wins the Vanguardia de la Ciència Award
07 07 2026
Aura Muntasell, IBB-UAB researcher, associate Professor in the Department of Cell Biology, Physiology and Immunology at the UAB and researcher at the Hospital del Mar Medical Research Institute (IMIM), has been awarded the Vanguardia de la Ciencia Award, which recognises the most outstanding research achievements led by Spanish research institutions. Her award-winning project focuses on the development of an innovative cancer immunotherapy strategy with the potential to improve the effectiveness of current treatments. The research received 25% of the public vote.
CAR therapies for neurodegeneration: a big challenge with increasingly plausible solutions
30 06 2026
The Protein Folding and Conformational Diseases research group, led by Salvador Ventura, defines the criteria that CAR immunotherapies for neurodegenerative diseases must meet to advance both conceptually and in trials, which are still at a very preliminary stage, in a review study published in the journal Trends in Pharmacological Sciences.
New article: “GFP-like protein scaffolds for antigen grafting: Soluble and stable neoantigen display in mammalian-compatible platforms”
26 06 2026
Research Group: Nanobiotechnology
Detecting Alzheimer's disease in its early stages could be possible
26 06 2026
A recent study presents a method for detecting Alzheimer's disease before neuronal damage becomes extensive. The study used small plasma particles called exosomes, obtained through liquid biopsy, because they carry molecular information from their cells of origin. Despite the difficulty involved, preliminary studies are very promising in terms of the ability to capture brain-derived exosomes. This could make it feasible to detect the disease at very early stages and move towards a tool to support screening and monitoring, which is the objective of the research.